Viatris Equity-NMS: VTRS

Healthcare

Drug Manufacturers-Specialty & Generic

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$10.96
Today's high :$11.145
52W high :$15.6
1Y :-25.67%
5Y :-63.56%
EPS(TTM): :0.6276
Shares O/S :1.21 B
Market cap :13.5 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Viatris today?

Viatris (VTRS) share price as of August 12, 2022, is $11.13. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Viatris?

Yes, Indian Investors can invest in the Viatris (VTRS) Share by opening an international trading account with Angel One.

How can I purchase Viatris shares in India?

Purchasing Viatris (VTRS) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Viatris (VTRS) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Viatris?

Yes, you can purchase fractional shares of Viatris (VTRS) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Viatris?

The market capitalization of Viatris on August 14, 2022, is $13.5 B.

In which sector Viatris belongs?

Viatris operates in the Healthcare sector, specifically in the Drug Manufacturers-Specialty & Generic industry.

What documents are required to invest in Viatris stocks?

In order to invest in Viatris (VTRS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Viatris

Viatris Inc. is a global healthcare company. The Company has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its operations primarily in North America and Europe. Greater China segment includes its operations in China, Taiwan and Hong Kong. JANZ segment reflects its operations in Japan, Australia and New Zealand. Emerging Markets segment encompasses its presence in approximately 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as its anti-retroviral franchise. Its portfolio comprises approximately 1,400 approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. It operates approximately 40 manufacturing sites worldwide, which produces oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.